Kashinath Yadalam
Psychiatry · Lake Charles, LANPI 1588661508
Payments from drug & device makers
Across 434 payments — averaging $8736.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Janssen Research & Development, LLC$1.2M
- AbbVie$650K
- Genentech, Inc.$445K
- Sunovion Pharmaceuticals Inc.$399K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$387K
- Teva Pharmaceuticals USA, Inc.$213K
- plus $530K from 17 others
What the payments were for
- Food & beverage$15780%
- Education$4020%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Janssen Research & Development, LLC | 67 | $1,167,956 |
| AbbVie(2 entities) | 77 | $649,910 |
| Genentech, Inc. | 29 | $444,593 |
| Sunovion Pharmaceuticals Inc. | 85 | $398,957 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 21 | $387,206 |
| Teva Pharmaceuticals USA, Inc. | 24 | $213,392 |
| Boehringer Ingelheim | 12 | $184,493 |
| Sage Therapeutics, LLC | 22 | $166,607 |
| H. Lundbeck A S | 8 | $41,064 |
| Tolmar, Inc. | 5 | $28,316 |
| Acadia Pharmaceuticals Inc | 7 | $22,259 |
| Avanir Pharmaceuticals, Inc. | 5 | $21,659 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $11,967 |
| Boehringer Ingelheim International GmbH | 38 | $9,710 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $9,139 |
| Hoffmann-la Roche Limited | 2 | $8,500 |
| Merck | 2 | $8,292 |
| Shire North American Group Inc | 2 | $7,506 |
| GW Research Limited | 1 | $7,369 |
| Boehringer Ingelheim RCV GmbH & Co KG | 21 | $1,652 |
| Jazz Pharmaceuticals Inc. | 1 | $1,000 |
| Sumitomo Pharma America, Inc. | 1 | $160 |
| Neurocrine Biosciences, Inc. | 1 | $125 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INGREZZA$125
How this compares
$3,791,829 in reported general payments places this provider in the 95th percentile of 474 psychiatry providers in Louisiana.
Other psychiatry in Lake Charles
- Patrick HayesLake Charles$853K
- David MurdockLake Charles$18K
- Jayendra PatelLake Charles$13K
- Guy BrannonShreveport$1.4M
- Maria CruseThibodaux$522K
- Larry WarnerBaton Rouge$495K
- Gregory BrownShreveport$495K
- Arwen PodestaNew Orleans$466K
- Jasjit SinghShreveport$420K
- Aruna GullapalliMonroe$287K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.